Related Experiment Video
Updated: Nov 24, 2025

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy
Renata Rajtar-Salwa1, Tomasz Tokarek1, Paweł Petkow Dimitrow2
1Department of Cardiology and Cardiovascular Interventions, University Hospital, Jakubowskiego 2 St., 30-688 Krakow, Poland.
Insights
Reversed septal curvature (RSC) in hypertrophic cardiomyopathy patients is linked to higher high-sensitivity troponin I (hs-TnI) levels and increased provocable left ventricular outflow tract gradient (LVOTG). This suggests RSC may indicate a higher risk of ischemic events.
Area of Science:
- Cardiology
- Echocardiography
- Biomarkers
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
- Septal configuration is a key echocardiographic feature in HCM.
- The clinical significance of reversed septal curvature (RSC) in HCM requires further elucidation.
Purpose of the Study:
- To compare clinical and echocardiographic parameters in HCM patients stratified by septal configuration.
- To investigate the association between reversed septal curvature (RSC) and biomarkers like hs-TnI and NT-proBNP.
- To assess the relationship between RSC and left ventricular outflow tract gradient (LVOTG).
Main Methods:
- Retrospective analysis of 56 consecutive hypertrophic cardiomyopathy patients.
- Classification into reversed septal curvature (RSC) and non-RSC groups based on 4-chamber apical window views.
- Comparison of high-sensitivity troponin I (hs-TnI), NT-proBNP, and provocable left ventricular outflow tract gradient (LVOTG) between groups.
Main Results:
- Patients with RSC exhibited significantly higher levels of hs-TnI (p=0.001).
- A trend towards increased NT-proBNP was observed in the RSC group (p=0.056).
- Provocable LVOTG was significantly higher in patients with RSC (p=0.04), alongside prognostically unfavorable septal thickness.
Conclusions:
- Reversed septal curvature (RSC) in hypertrophic cardiomyopathy is associated with elevated hs-TnI levels.
- RSC may serve as a marker for increased risk of ischemic events in HCM patients.
- Provocable LVOTG is a significant finding in patients with RSC.
Abstract:
The aim of study was to compare patients with hypertrophic cardiomyopathy divided according to septal configuration assessed in a 4-chamber apical window. The study group consisted of 56 consecutive patients. Reversed septal curvature (RSC) and non-RSC were diagnosed in 17 (30.4%) and 39 (69.6%) patients, respectively. Both RSC and non-RSC groups were compared in terms of the level of high-sensitivity troponin I (hs-TnI), NT-proBNP (absolute value), NT-proBNP/ULN (value normalized for sex and age), and echocardiographic parameters, including left ventricular outflow tract gradient (LVOTG). A higher level of hs-TnI was observed in RSC patients as compared to the non-RSC group (102 (29.2-214.7) vs. 8.7 (5.3-18) (ng/l), p = 0.001). A trend toward increased NT-proBNP value was reported in RSC patients (1279 (367.3-1186) vs. 551.7 (273-969) (pg/ml), p = 0.056). However, no difference in the NT-proBNP/ULN level between both groups was observed. Provocable LVOTG was higher in RSC as compared to non-RSC patients (51 (9.5-105) vs. 13.6 (7.5-31) (mmHg), p = 0.04). Furthermore, more patients with RSC had prognostically unfavourable increased septal thickness to left LV diameter at the end diastole ratio. Patients with RSC were associated with an increased level of hs-TnI, and the only trend observed in this group was for the higher NT-proBNP levels. RSC seems to be an alerting factor for the risk of ischemic events. Not resting but only provocable LVOTG was higher in RSC as compared to non-RSC patients.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:21Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction